Mead Johnson Nutrition Company (MJN) Shares are Down -1.07%

Mead Johnson Nutrition Company (MJN) : During the past 4 weeks, traders have been relatively bearish on Mead Johnson Nutrition Company (MJN), hence the stock is down -8.81% when compared to the S&P 500 during the same period. However, in the past 1 week, the selling of the stock is down by -1.59% relative to the S&P 500. The 4-week change in the price of the stock is -10.65% and the stock has fallen -1.07% in the past 1 week.

The stock has recorded a 20-day Moving Average of 6.26% and the 50-Day Moving Average is 11.01%.The 200 Day SMA reached 4.8% Mead Johnson Nutrition Company has dropped 10.49% during the last 3-month period . Year-to-Date the stock performance stands at -1.24%.


Mead Johnson Nutrition Company (MJN) : Currently there are 6 street experts covering Mead Johnson Nutrition Company (MJN) stock. The most bullish and bearish price target for the stock is $96 and $75 respectively for the short term. The average price target of all the analysts comes to $86.5. The estimated standard deviation from the target is $6.89.

For the current week, the company shares have a recommendation consensus of Buy. Mead Johnson Nutrition Company (NYSE:MJN): stock was range-bound between the intraday low of $76.303 and the intraday high of $77.13 after having opened at $76.84 on Fridays session. The stock finally closed in the red at $76.84, a loss of -0.70%. The stock remained in the red for the whole trading day. The total traded volume was 1,625,937 shares. The stock failed to cross $77.13 in Fridays trading. The stocks closing price on Thursday was $77.29.

Mead Johnson Nutrition Company (Mead Johnson) is a global pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, childrens nutrition and other nutritional products. Its product portfolio includes routine and specialty infant formulas, childrens milks and milk modifiers, dietary supplements for pregnant and breastfeeding mothers, pediatric vitamins, and products for pediatric metabolic disorders. The Company operates through three segments: Asia, Latin America and North America/Europe. The Companys Enfa family of brands, including Enfamil infant formula, is a brand franchise in pediatric nutrition. Its product portfolio addresses a range of nutritional needs for infants, children and expectant and nursing mothers. The Company markets its portfolio of more than 70 products to mothers, healthcare professionals and retailers in more than 50 countries in Asia, North America, Latin America and Europe.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.